International Cancer Cluster Showcase 2019

/in , , /by

Event Details

International Cancer Cluster Showcase (ICCS) has been organized since 2012 as a satellite event to the BIO International Convention in the US.

It is a joint initiative with partners from Europe and North America. The next ICCS is taking place June 3rd, 2019 in Philadelphia.

 

AGENDA

11:30 – 12:30 p.m.
REGISTRATION AND LIGHT LUNCH with POSTER SESSION 

12:30 – 12:45 p.m.
Opening and Welcome by ICCS Organizing Partners and Sponsors
Welcome Notes: Allison Hilton, Healthcare Corporate Banking, DNB Healthcare & Larry Blandford, Executive Vice President, Precision Value & Health

12:45 – 1:15 p.m.
Company Pitches – I
Kernal, ISOMA Therapeutics, Vaccibody, Memo Therapeutics, Chimeric Therapeutics, Ability Pharma

1:15 – 1:20 p.m.
Takeda Oncology Presentation
Chris Hurff, Senior Director Business Development, Takeda Oncology

1:20 – 1:45 p.m.
Company Pitches – II
OncoInvent, Vironika, Cytosolix, eTheRNA, Neophore

1:45 – 1:50 p.m.
National Cancer Institute (NCI) Presentation
Michael Salgaller, Supervisory Specialist Technology Transfer Center, NCI, National Institutes of Health

1:50 – 2:15 p.m.
NETWORKING BREAK & POSTER SESSION

2:15 – 2:20 p.m.
Boehringer Ingelheim Presentation
Marcio Lasaro, Associate Director Cancer Immunology and Biotherapeutics Business Development and Licensing

2:20 – 2:50 p.m.
Company Pitches – III
Domain Therapeutics, Carisma Therapeutics, BioInvent, Biomunex, Bryologics, Valo Therapeutics

2:50 – 3:00 p.m.
Mass Medical Angels

3:00 – 3:30 p.m.
Company Pitches – IV
BioArray Genetics, RS Research, Virion Therapeutics, KisoJi Biotechnology, Oncoheroes

3:30 – 3:35 p.m.
Closing Remarks

3:35 – 4:30 p.m.
NETWORKING RECEPTION & POSTER SESSION

 

Profiles of all the presenting companies and more information can be found on the official International Cancer Cluster Showcase website.